The FDA has granted orphan drug designation to the oral agent OPN-6602 for the treatment of patients with relapsed or ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

A charity with ties to Baton Rouge, has cyclists on the road again, riding to raise awareness and money for Multiple Myeloma ...

Films like Strong: Living with Multiple Myeloma are essential. Multiple Myeloma is not exactly high on the list of diseases ...

The future is bright for our bone marrow transplant program,” Dr. Hana Safah said. "We look forward to advancing blood cancer ...

For details, see the “What should I know before using Pomalyst?” section. Multiple myeloma is a blood cancer that affects your bone marrow. It causes a buildup of cancer cells, which ...

The PDUFA action date for an FDA decision for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma ...

Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...